Skip to main content
Clinical Trials/NCT02031393
NCT02031393
Unknown
Not Applicable

Establishing First Trimester Sonographic, Biochemical and Clinical Markers for the Identification of High Risk Twin in the First Trimester

Assaf-Harofeh Medical Center1 site in 1 country300 target enrollmentSeptember 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Small for Gestational Age (Disorder)
Sponsor
Assaf-Harofeh Medical Center
Enrollment
300
Locations
1
Primary Endpoint
The development of preeclampsia
Last Updated
12 years ago

Overview

Brief Summary

The purpose of this study is to determine whether we can establish different markers suc as mean arterial pressure , flow in the uterine arteries, biochemical markers in maternal blood and more un the first trimester, in order to screen for twin pregnancies that are more likely to develop adverse pregnancy outcome: early delivery, pre eclampsia or small fetuses.

Registry
clinicaltrials.gov
Start Date
September 2009
End Date
July 2014
Last Updated
12 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • pregnant women from 11 -14 weeks of gestation

Exclusion Criteria

  • nuchal thickness above 3 mm,
  • Chronic hypertension,
  • thrombophilia,

Outcomes

Primary Outcomes

The development of preeclampsia

Time Frame: after delivery

the women will be approached after birth to asses whether they developed preeclampsia or pregnancy induced hypertension

Secondary Outcomes

  • intra uterine growth restriction(after delivery)

Study Sites (1)

Loading locations...

Similar Trials